《沪深股市》上证深成创板半日以高位收市 贵州茅台升4%再创历史高
今日为A股鼠年最後一个交易日。内地昨日报告新增确诊病例14例,连续三日无本土病例。人民银行公开市场今日进行200亿元人民币(下同)7天期逆回购操作,单日净回笼800亿元。人汇持续走强,人民币兑美元中间价上调,创近32个月高,上证深成高开後持续造好,创板更升逾2%。
上证半日升37点或1%,以高位收报3,640点;深成升295点或1.9%,以高收报15,926点;沪深300指数升95点或1.7%,收报5,781点。创业板指数升71点或2.2%,收报3,406点,成交943亿元。沪深两市成交分别为2,357亿元及2,892亿元。
大型中资金融股表现向好,建行(601939.SH)、工行(601398.SH)、国寿(601628.SH)升1.2%-2.5%。部份银行股走弱,平安银行(000001.SZ)、重庆银行(601963.SH)、无锡银行(600908.SH)跌2%-6.4%。
白酒股造好,顺鑫农业(000860.SZ)、老干白酒(600559.SH)分别升5%、3%。贵州茅台(600519.SH)拟实施中华片区酒库续建工程等项目,股价再创新高见2,589.99元,半日升4%造2,556元。
消费电子股上升,新纶科技(002341.SZ)、歌尔股份(002241.SZ)、漫步者(002351.SZ)涨停。科大讯飞(002230.SZ)、蓝思科技(300433.SZ)分别扬8.5%及7.4%。
医美概念股上扬,朗姿股份(002612.SZ)涨停。华东医药(000963.SZ)、爱美客(300896.SZ)分别扬7.6%、8.3%。上交所公布,监於康熙诺(688185.SH)、君实生物(688180.SH)等被纳入沪股通名单。根据指数规则,上交所与中证指数有限公司决定自下周四(18日)起,将康希诺、君实生物纳入上证沪股通指数样本。两股半日大涨18%及8.2%。
顺丰控股(002352.SZ)定增募资不逾220亿人币拟要约收购嘉里物流51.8%股份,股价开市涨停。
格力地产(600185.SH)暂停重大资产重组事项,股价现挫9.3%。(ta/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.